Publicaciones
-
De Paepe B, Martin JJ, Herbelet S, Jimenez-Mallebrera C, Iglesias-Jimenez E, Jou-Munoz C, Weis J and De Bleecker JL.
Activation of osmolyte pathways in inflammatory myopathy and Duchenne muscular dystrophy points to osmoregulation as a contributing pathogenic mechanism
LABORATORY INVESTIGATION . 96(8): 872-884. Nº de citas: 12
-
Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Calzada-Hernández J, Borlan S, Gimenez-Roca C and Rivera J.
Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population
RHEUMATOLOGY INTERNATIONAL . 36(7): 905-910. Nº de citas: 26
-
Sánchez-Manubens J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E and Calzada-Hernández J.
Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 34(3): 139-144. Nº de citas: 14
-
Calzada-Hernández J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Ricart S, Martín-de-Carpi J, García de Vicuña-Muñoz C, Torrente V, Sánchez-Manubens J, Giménez-Roca CI, Rozas L, Juncosa-Morros T, Fortuny-Guasch C and Noguera-Julián A.
Tuberculosis in pediatric patients treated with anti-TNFa drugs: a cohort study
PEDIATRIC RHEUMATOLOGY . 13: 54-54. Nº de citas: 27
-
Nakagawa K, Gonzalez-Roca E, Souto A, Kawai T, Umebayashi H, Campistol-Plana J, Cañellas J, Takei S, Kobayashi N, Callejas-Rubio JL, Ortego-Centeno N, Ruiz-Ortiz E, Rius F, Anton-Lopez J, Iglesias-Jimenez E, Jimenez-Treviño S, Vargas C, Fernandez-Martin J, Calvo I, Hernández-Rodríguez J, Mendez M, Dordal MT, Basagaña M, Bujan S, Yashiro M, Kubota T, Koike R, Akuta N, Shimoyama K, Iwata N, Saito MK, Ohara O, Kambe N, Yasumi T, Izawa K, Kawai T, Heike T, Yagüe J, Nishikomori R and Aróstegui JI.
Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes
ANNALS OF THE RHEUMATIC DISEASES . 74(3): 603-610. Nº de citas: 79
-
Giménez-Roca CI, Iglesias-Jimenez E, Torrente-Segarra V, Bou-Torrent R, Sánchez-Manubens J, Calzada-Hernández J, Samuel Hernandez Baldizon, Ricart S and Anton-Lopez J.
Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age
RHEUMATOLOGY INTERNATIONAL . 35(2): 323-326. Nº de citas: 12
-
Bou-Torrent R, Iglesias-Jimenez E and Anton-Lopez J.
Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis
CURRENT RHEUMATOLOGY REPORTS . 16(8): 437-437. Nº de citas: 12
-
Iglesias-Jimenez E, Torrente V, Bou-Torrent R, Ricart S, Maria Isabel Gonzalez Fernandez, Sánchez-Manubens J, Calzada-Hernández J and Anton-Lopez J.
Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-alpha therapy: a clinical practice observational study of patients who discontinued treatment
RHEUMATOLOGY INTERNATIONAL . 34(8): 1053-1057. Nº de citas: 21
-
Iglesias-Jimenez E, Eleftheriou D, Mankad K, Prabhakar P and Brogan PA.
Microscopic Polyangiitis Presenting With Hemorrhagic Stroke
JOURNAL OF CHILD NEUROLOGY . 29(8): 1-4. Nº de citas: 8
-
Iglesias-Jimenez E, Camacho Lovillo M, Delgado Pecellín I, Lirola Cruz MJ, Falcón Neyra MD, Salazar Quero JC, Bernabeu-Wittel J, González Valencia JP and Neth O.
Successful Management of Churg-Strauss Syndrome Using Omalizumab as; Adjuvant Immunomodulatory Therapy: First Documented Pediatric Case
PEDIATRIC PULMONOLOGY . 49(3): 78-81. Nº de citas: 22